Rights and permissions
About this article
Cite this article
Topotecan + cisplatin a promising option for SCLC. Inpharma Wkly. 1641, 15 (2008). https://doi.org/10.2165/00128413-200816410-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816410-00029